• news.cision.com/
  • AstraZeneca/
  • NEW DATA FOR INVESTIGATIONAL DIABETES DRUG SAXAGLIPTIN DEMONSTRATES POTENTIAL FOR TYPE 2 DIABETES TREATMENT
English

NEW DATA FOR INVESTIGATIONAL DIABETES DRUG SAXAGLIPTIN DEMONSTRATES POTENTIAL FOR TYPE 2 DIABETES TREATMENT

Report this content

• New data presented for the first time at EASD 2008
• Saxagliptin with metformin as initial combination therapy lowered A1C
• Improvements demonstrated across key measures of glucose control studied in
treatment-naïve people with type 2 diabetes

Please see attached pdf

Subscribe

Documents & Links